Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol vs Glucantime vs Combination for Cutaneous Leishmaniasis
NCT00004755Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 1995
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of allopurinol in cutaneous leishmaniasis (CL), sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 1995; status: completed.
02
Drugs
allopurinol
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT00004755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004755.